Trial · NCT04230577
Registered outcomes92
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
41 to 60 of 92
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Benton Visual Memory Test; Total Trials 1 | Change from Pre-Treatment Baseline to 1-Week after Series 1 | Total Trials 1-3. Learning Measure for Visuospatial memory Min 0 and max 36; higher score better outcome Total possible for each trial is 12 points. Sum of Total is learning score. Participant is presented with 6 figures. They are given 10 secs to view 6 pictures. Immediately asked to recall and draw the figures. This is repeated 3 times. Up to 2 points per figure. Scoring based on accuracy and placement of figure parts: A score of 0, 1 recognizable and incorrectly placed, 1 accurate or correctly placed or 2 both accurate and correctly placed; 0 is given if part is omitted or unrecognizable. |
| Secondary | Benton Visual Memory Test; Total Trials 2 | Change from Pre-Treatment Baseline to 1-Month after Series 1 | Total Trials 1-3. Learning Measure for Visuospatial memory Min 0 and max 36; higher score better outcome Total possible for each trial is 12 points. Sum of Total is learning score. Participant is presented with 6 figures. They are given 10 secs to view 6 pictures. Immediately asked to recall and draw the figures. This is repeated 3 times. Up to 2 points per figure. Scoring based on accuracy and placement of figure parts: A score of 0, 1 recognizable and incorrectly placed, 1 accurate or correctly placed or 2 both accurate and correctly placed; 0 is given if part is omitted or unrecognizable. |
| Secondary | Benton Visual Memory Test; Total Trials 3 | Change from 1-Week to 1-Month after Series 1 | Total Trials 1-3. Learning Measure for Visuospatial memory Min 0 and max 36; higher score better outcome Total possible for each trial is 12 points. Sum of Total is learning score. Participant is presented with 6 figures. They are given 10 secs to view 6 pictures. Immediately asked to recall and draw the figures. This is repeated 3 times. Up to 2 points per figure. Scoring based on accuracy and placement of figure parts: A score of 0, 1 recognizable and incorrectly placed, 1 accurate or correctly placed or 2 both accurate and correctly placed; 0 is given if part is omitted or unrecognizable. |
| Secondary | Benton Visual Memory Test; Total Trials 4 | Change from Pre-Treatment Baseline to 1-Week after Series 2 | Total Trials 1-3. Learning Measure for Visuospatial memory Min 0 and max 36; higher score better outcome Total possible for each trial is 12 points. Sum of Total is learning score. Participant is presented with 6 figures. They are given 10 secs to view 6 pictures. Immediately asked to recall and draw the figures. This is repeated 3 times. Up to 2 points per figure. Scoring based on accuracy and placement of figure parts: A score of 0, 1 recognizable and incorrectly placed, 1 accurate or correctly placed or 2 both accurate and correctly placed; 0 is given if part is omitted or unrecognizable. |
| Secondary | Benton Visual Memory Test; Delayed Recall 1 | Change from Pre-Treatment Baseline to 1-Week after Series 1 | Measures Delayed (20 minute) Recall for Visuospatial memory. {participant completes other tasks during delay) Min 0 and max 12; higher score better outcome Participant is asked to draw the figures from memory after a 20 minute delay (other tasks completed during this time). Total possible: 12 Scoring is based on accuracy and placement: 0 if unrecognizable or omitted, 1 recognizable, 1 either accurate or correctly placed or 2 both accurate and correctly placed, per figure. |
| Secondary | Benton Visual Memory Test; Delayed Recall 2 | Change from Pre-Treatment Baseline to 1-Month after Series 1 | Measures Delayed (20 minute) Recall for Visuospatial memory. {participant completes other tasks during delay) Min 0 and max 12; higher score better outcome Participant is asked to draw the figures from memory after a 20 minute delay (other tasks completed during this time). Total possible: 12 Scoring is based on accuracy and placement: 0 if unrecognizable or omitted, 1 recognizable, 1 either accurate or correctly placed or 2 both accurate and correctly placed, per figure. |
| Secondary | Benton Visual Memory Test; Delayed Recall 3 | Change from 1-Week to 1-Month after Series 1 | Measures Delayed (20 minute) Recall for Visuospatial memory. {participant completes other tasks during delay) Min 0 and max 12; higher score better outcome Participant is asked to draw the figures from memory after a 20 minute delay (other tasks completed during this time). Total possible: 12 Scoring is based on accuracy and placement: 0 if unrecognizable or omitted, 1 recognizable, 1 either accurate or correctly placed or 2 both accurate and correctly placed, per figure. |
| Secondary | Benton Visual Memory Test; Delayed Recall 4 | Change from Pre-Treatment Baseline to 1-Week after Series 2 | Measures Delayed (20 minute) Recall for Visuospatial memory. {participant completes other tasks during delay) Min 0 and max 12; higher score better outcome Participant is asked to draw the figures from memory after a 20 minute delay (other tasks completed during this time). Total possible: 12 Scoring is based on accuracy and placement: 0 if unrecognizable or omitted, 1 recognizable, 1 either accurate or correctly placed or 2 both accurate and correctly placed, per figure. |
| Secondary | Beck Depression Inventory (BDI) 1 | Change from Pre-Treatment Baseline to 1-Week after Series 1 | 21 item Questionnaire; Measures mood symptoms. Min 0 and max 63 0-13 minimal; 14-19 mild, 20-29 moderate, 30-63 severe; lower scores = better outcome Score per item: 1-3. |
| Secondary | Beck Depression Inventory (BDI) 2 | Change from Pre-Treatment Baseline to 1-Month after Series 1 | 21 item Questionnaire; Measures mood symptoms. Min 0 and max 63 0-13 minimal; 14-19 mild, 20-29 moderate, 30-63 severe; lower scores = better outcome Score per item: 1-3. |
| Secondary | Beck Depression Inventory (BDI) 3 | Change from 1-Week to 1-Month after Series 1 | 21 item Questionnaire; Measures mood symptoms. Min 0 and max 63 0-13 minimal; 14-19 mild, 20-29 moderate, 30-63 severe; lower scores = better outcome Score per item: 1-3. |
| Secondary | Beck Depression Inventory (BDI) 4 | Change from Pre-Treatment Baseline to 1-Week after Series 2 | 21 item Questionnaire; Measures mood symptoms. Min 0 and max 63 0-13 minimal; 14-19 mild, 20-29 moderate, 30-63 severe; lower scores = better outcome Score per item: 1-3. |
| Secondary | Post Traumatic Stress Disorder (PCL) 1 | Change from Pre-Treatment Baseline to 1-Week after Series 1 | 17-item, symptom questionnaire Higher scores indicates greater endorsement of symptoms Min 17 and max 85 Reliable decrease 5-10 Clinically meaningful decrease 10-20 points Lower scores = better outcome Score ranges from 1-5 for each item. |
| Secondary | Post Traumatic Stress Disorder (PCL) 2 | Change from Pre-Treatment Baseline to 1-Month after Series 1 | 17-item, symptom questionnaire Higher scores indicates greater endorsement of symptoms Min 17 and max 85 Reliable decrease 5-10 Clinically meaningful decrease 10-20 points Lower scores = better outcome Score ranges from 1-5 for each item. |
| Secondary | Post Traumatic Stress Disorder (PCL) 3 | Change from 1-Week to 1-Month after Series 1 | 17-item, symptom questionnaire Higher scores indicates greater endorsement of symptoms Min 17 and max 85 Reliable decrease 5-10 Clinically meaningful decrease 10-20 points Lower scores = better outcome Score ranges from 1-5 for each item. |
| Secondary | Post Traumatic Stress Disorder (PCL) 4 | Change from Pre-Treatment Baseline to 1-Week after Series 2 | 17-item, symptom questionnaire Higher scores indicates greater endorsement of symptoms Min 17 and max 85 Reliable decrease 5-10 Clinically meaningful decrease 10-20 points Lower scores = better outcome Score ranges from 1-5 for each item. |
| Secondary | Visual Analog Pain Rating Scale (VAS) 1 | Change from Pre-Treatment Baseline to 1-Week after Series 1 | Current Pain Rating scale of 1-10 Lower score = better outcome \*must be lower than 7 at entry into study for study inclusion Participant rates current level of pain (includes body, muscular, headache etc) by marking a line on a continuous scale from 1-10. |
| Secondary | Visual Analog Pain Rating Scale (VAS) 2 | Change from Pre-Treatment Baseline to 1-Month after Series 1 | Current Pain Rating scale of 1-10 Lower score = better outcome \*must be lower than 7 at entry into study for study inclusion Participant rates current level of pain (includes body, muscular, headache etc) by marking a line on a continuous scale from 1-10. |
| Secondary | Visual Analog Pain Rating Scale (VAS) 3 | Change from 1-Week to 1-Month after Series 1 | Current Pain Rating scale of 1-10 Lower score = better outcome \*must be lower than 7 at entry into study for study inclusion Participant rates current level of pain (includes body, muscular, headache etc) by marking a line on a continuous scale from 1-10. |
| Secondary | Visual Analog Pain Rating Scale (VAS) 4 | Change from Pre-Treatment Baseline to 1-Week after Series 2 | Current Pain Rating scale of 1-10 Lower score = better outcome \*must be lower than 7 at entry into study for study inclusion Participant rates current level of pain (includes body, muscular, headache etc) by marking a line on a continuous scale from 1-10. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04230577/registered?page=3